Hohimer Wealth Management, LLC Vertex Pharmaceuticals Inc Transaction History

Hohimer Wealth Management, LLC

$455 Million
Q3 2024

A detailed history of Hohimer Wealth Management, LLC transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Hohimer Wealth Management, LLC holds 2,320 shares of VRTX stock, worth $946,977. This represents 0.24% of its overall portfolio holdings.

Number of Shares

2,320

Previous 2,250 3.11%

Holding current value

$946,977

Previous $1.05 Million 2.28%

% of portfolio

0.24%

Previous 0.25%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 18, 2024	BUY	$460.0 - $505.78 $32,200 - $35,404	70 Added 3.11%	2,320 $1.08 Million
Q2 2024 Aug 02, 2024	SELL	$392.81 - $485.53 $248,648 - $307,340	-633 Reduced 21.96%	2,250 $1.05 Million
Q1 2024 May 07, 2024	SELL	$407.69 - $446.08 $19,976 - $21,857	-49 Reduced 1.67%	2,883 $1.21 Million
Q4 2023 Feb 09, 2024	BUY	$343.0 - $410.68 $8,232 - $9,856	24 Added 0.83%	2,932 $1.19 Million
Q3 2023 Nov 20, 2023	BUY	$338.18 - $362.46 $10,483 - $11,236	31 Added 1.08%	2,908 $1.01 Million
Q2 2023 Jul 27, 2023	SELL	$314.42 - $351.91 $23,895 - $26,745	-76 Reduced 2.57%	2,877 $1.01 Million
Q1 2023 May 02, 2023	SELL	$283.23 - $323.1 $15,294 - $17,447	-54 Reduced 1.8%	2,953 $930,000
Q4 2022 Feb 01, 2023	SELL	$285.76 - $321.48 $5,429 - $6,108	-19 Reduced 0.63%	3,007 $868,000
Q3 2022 Nov 02, 2022	SELL	$273.83 - $305.53 $1,095 - $1,222	-4 Reduced 0.13%	3,026 $876,000
Q2 2022 Jul 25, 2022	SELL	$234.96 - $292.55 $769,494 - $958,101	-3,275 Reduced 51.94%	3,030 $854,000
Q1 2022 May 03, 2022	BUY	$221.42 - $260.97 $128,645 - $151,623	581 Added 10.15%	6,305 $1.65 Million
Q4 2021 Jan 25, 2022	SELL	$177.01 - $223.45 $37,349 - $47,147	-211 Reduced 3.56%	5,724 $1.26 Million
Q3 2021 Oct 18, 2021	BUY	$181.39 - $202.99 $26,482 - $29,636	146 Added 2.52%	5,935 $1.08 Million
Q2 2021 Jul 12, 2021	BUY	$187.49 - $221.1 $536,033 - $632,124	2,859 Added 97.58%	5,789 $1.17 Million
Q1 2021 Apr 12, 2021	SELL	$207.02 - $241.31 $524,381 - $611,238	-2,533 Reduced 46.37%	2,930 $630,000
Q4 2020 Jan 11, 2021	SELL	$207.01 - $276.09 $6,831 - $9,110	-33 Reduced 0.6%	5,463 $1.29 Million
Q3 2020 Nov 13, 2020	BUY	$255.65 - $303.1 $22,752 - $26,975	89 Added 1.65%	5,496 $1.21 Million
Q2 2020 Jul 14, 2020	SELL	$225.48 - $295.8 $90,417 - $118,615	-401 Reduced 6.9%	5,407 $1.57 Million
Q1 2020 May 05, 2020	SELL	$199.77 - $247.81 $416,720 - $516,931	-2,086 Reduced 26.43%	5,808 $1.56 Million
Q4 2019 Feb 14, 2020	BUY	$166.71 - $223.91 $1.32 Million - $1.77 Million	7,894 New	7,894 $1.73 Million

Others Institutions Holding VRTX

# of Institutions

1,724

Shares Held

221M

Call Options Held

1.58M

Put Options Held

1.36M

View Full List

About VERTEX PHARMACEUTICALS INC

Ticker VRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 256,691,008
Market Cap $105B
Description
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...

More about VRTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Hohimer Wealth Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Hohimer Wealth Management, LLC with notifications on news.

Account

Hohimer Wealth Management, LLC Vertex Pharmaceuticals Inc Transaction History